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Editorial
What neurodegeneration, 
brain malformation and cancer 
might have in common? 
An abnormal gene expression!
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O QUE NEURODEGENERAÇÃO, MALFORMAÇÃO CEREBRAL E CÂNCER PODEM TER EM COMUM? UMA 
EXPRESSÃO GENÉTICA ANORMAL!
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In this issue of Arquivos de Neuro­
Psiquiatria, three interesting publications 
over totally different subjects, but having 
Genetics as a common ground might be 
appreciated.
In the more classical manuscript, Va-
ladares and cols.1 presented their clinical 
and molecular findings regarding a large 
family with 10 affected individuals with 
juvenile neuronal ceroid-lipofuscinosis 
(CLN3), in which the common 1.03 kb de-
letion of CLN3 gene was found. In this se-
vere neurodegenerative disorder, in which 
almost all patients shared the same mu-
tation, it is noteworthy, but not surpris-
ing, that phenotype and clinical presenta-
tion were moderately variable: variability 
in Mendelian disorder are more common 
than initially believed and represent an ad-
ditional challenge to clinicians. Addition-
ally, investigation of large families like this 
one is a good way to look for new disor-
ders, or to collect more clinical informa-
tion on already indentified genetic condi-
tions. And time is rushing, as large con-
sanguineous families are becoming rarer! 
In the second publication, Macha-
do and cols.2 studied genomic imbal-
ances in fetuses with holoprosencepha-
ly (HPE), a devastating brain malforma-
tion in which both genetic and environ-
mental factors might be involved. Using 
a technique known as comparative ge-
nomic hybridization (CGH), which is be-
coming a standard of care for investiga-
tion of several conditions, including au-
tism, developmental delay/mental retar-
dation and a wide range of brain or sys-
temic congenital malformations, they de-
tected submicroscopic chromosomal ab-
normalities in four fetuses with HPE. In-
tensive use of CGH-array might help to 
identify chromosomal regions in which a 
critical gene for a determined phenotype 
is located. Nevertheless, interpretation of 
CGH-array results should be always made 
with caution: it is recommended to veri-
fy if detected abnormalities were inherited 
from one of the parents or occurred as a de 
novo event. Clinical significance of inherit-
ed submicroscopic abnormalities is uncer-
tain, since variants are frequently found. It 
is also useful to confirm the detected ab-
normal imbalance with a complementary 
technique, such as fluorescent in situ hy-
bridization (FISH), to validate the result 
of CGH. Finally, in order to give an ap-
propriate counseling, we should be aware 
that an apparently de novo genomic rear-
rangement might be caused by a balanced 
translocation in one of the parents, which 
might bring for his descendents an elevat-
ed risk for chromosomal abnormalities. 
The third publication, from Vulcani-
Freitas and cols.3 is a study about expres-
sion of the gene PRAME in medulloblas-
toma (MB), a malignant cerebellar tumor 
more commonly seen in childhood. Using 
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real-time PCR to quantify the messenger RNA coded by 
PRAME, they were able to demonstrate in samples of 37 
patients with MB an overexpression of this message in 31 
of them. It has been previously reported that upregula-
tion of PRAME is associated with poor clinical outcome 
in some solid tumors, a fact that was not confirmed in 
this sample of NB. It is universally accepted that cancer 
biogenesis is related to change in the pattern of gene ex-
pression, and to find good biological markers for tumors, 
that also can be used as therapeutic targets, is a long cov-
eted holy grail. 
Patterns of gene expression do not explain everything, 
but everything in living organisms might somehow be 
controlled by regulation of gene expression. It is in fact 
more appropriate to say Control your genes! instead of 
Control your nerves! 
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